Pancreas

Gastroenterology. 2022;162(1):122–34

Iannuzzi JP, King JA, Leong JH, Quan J, Windsor JW, Tanyingoh D, Coward S, Forbes N, Heitman SJ, Shaheen AA, Swain M, Buie M, Underwood FE, Kaplan GG

Global incidence of acute pancreatitis is increasing over time: A systematic review and meta-analysis


Background and aims: Acute pancreatitis (AP) is a common disease with significant associated morbidity and mortality. The authors performed a systematic review and meta-analysis of population-based studies to explore the changing temporal trends of AP incidence globally.
Methods: They performed a systematic literature search to identify population-based studies reporting the annual incidence of AP. Abstracts were assessed independently to identify applicable articles for full-text review and data extraction. Join point temporal trend analyses were performed to calculate the average annual percent change (AAPC) with 95% confidence intervals (CIs). The AAPCs were pooled in a meta-analysis to capture the overall and regional trends in AP incidence over time. Temporal data were summarized in a static map and an interactive, web-based map.
Results: 44 studies reported the temporal incidence of AP (online interactive map: https://kaplan-acute-pancreatitis-ucalgary.hub.arcgis.com/). The incidence of AP has increased from 1961 to 2016 (AAPC, 3.07%; 95% CI: 2.30–3.84%; n = 34). Increasing incidence was observed in North America (AAPC, 3.67%; 95% CI: 2.76–4.57%; n = 4) and Europe (AAPC, 2.77%; 95% CI: 1.91–3.63%; n = 23). The incidence of AP was stable in Asia (AAPC, -0.28%; 95% CI: -5.03–4.47%; n = 4).

Conclusions: This meta-analysis provides a comprehensive overview of the global incidence of acute pancreatitis (AP) over the last 56 years and demonstrates a steadily rising incidence over time in most countries of the Western world. More studies are needed to better define the changing incidence of AP in Asia, Africa, and Latin America.

Dr. G.G. Kaplan, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada,
E-Mail: ggkaplan@ucalgary.ca

DOI: DOI: 10.1053/j.gastro.2021.09.043

Back to overview

this could be of interest:

Changes in metabolic syndrome status are associated with altered risk of pancreatic cancer: A nationwide cohort study

Gastroenterology. 2022;162(2):509–20.e7

Does hyperlipasemia predict worse clinical outcomes in COVID-19? A multicenter retrospective cohort study

J Clin Gastroenterol. 2022;56(3):e227–31

More articles on the topic